Results 161 to 170 of about 37,793 (186)
Remdesivir as a potent antiviral against prototype and current epidemic Oropouche virus strains (BeAn19991 and PE-IAM4637). [PDF]
Virus ResYoshikawa R, Ishii Y, Sano N, Yasuda J.
europepmc +1 more source
Repurposing of FDA-Approved Antiviral Drugs Against Monkeypox Virus: Comparative In Vitro Screening and Structure Based In Silico Studies. [PDF]
Pharmaceuticals (Basel)Moatasim Y +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hospital Pharmacy, 2021
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing ...
Terri L. Levien, Danial E. Baker
openaire +2 more sources
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing ...
Terri L. Levien, Danial E. Baker
openaire +2 more sources
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns
Clinical Microbiology and Infection, 2021Haleh Bagheri +2 more
exaly
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
Clinical Infectious Diseases, 2021Katherine K Perez +2 more
exaly